Healthark, a global healthcare consulting and technology firm, has unveiled Curie Clinical a dedicated agentic AI module designed to revolutionize clinical research operations. Built on the broader Curie enterprise AI platform, this innovation integrates autonomous, context-aware agents at the core of study execution, moving beyond conventional automation to proactive, insight-driven management.

Curie Clinical orchestrates the full clinical lifecycle:

Early-stage protocol development and study design.

Automated site feasibility and performance monitoring.

Real-time deviation tracking and training coordination.

Generation of monitoring visit reports and narrative drafting.

Ongoing oversight with built-in regulatory compliance.

By handling these routine yet critical tasks, the platform empowers clinical operations teams, medical writers, CRAs, and safety experts to prioritize scientific innovation and strategic decisions.

Benefits highlighted include:

Up to 70% reduction in documentation and review timelines.

Approximately 50% cost savings through streamlined processes.

Real-time visibility and control over workflows.

Enhanced resource allocation for high-value activities.

Dhaval Vasavada, Associate Director of Information, Data, and Technology at Healthark, emphasized: “We are confident that with Curie Clinical, research teams can move faster, reduce operational overhead, and gain real-time control over clinical workflows. This is not incremental automation it’s a move to agentic AI that autonomously powers insight-driven clinical operations.”

Curie Clinical reflects the maturing agentic AI trend where systems act independently toward goals tailored for the stringent demands of clinical research. As trials grow more complex amid regulatory scrutiny, tools like this promise to accelerate timelines, lower barriers, and improve data quality.

Healthark positions Curie Clinical as a cornerstone for its broader Curie ecosystem, unifying data, compliance, and automation across healthcare functions.